Mindaros, Romeo P.

HRN: 24-38-15  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/10/2024
01/16/2024
IVT
300mg
Q6
Necrotic 3rd, 4th Digit Right Foot
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft TissueMultiple Infections (tick All Sites)    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: